Literature DB >> 11976218

Time to talk SENS: critiquing the immutability of human aging.

Aubrey D N J de Grey1, Bruce N Ames, Julie K Andersen, Andrzej Bartke, Judith Campisi, Christopher B Heward, Roger J M McCarter, Gregory Stock.   

Abstract

Aging is a three-stage process: metabolism, damage, and pathology. The biochemical processes that sustain life generate toxins as an intrinsic side effect. These toxins cause damage, of which a small proportion cannot be removed by any endogenous repair process and thus accumulates. This accumulating damage ultimately drives age-related degeneration. Interventions can be designed at all three stages. However, intervention in metabolism can only modestly postpone pathology, because production of toxins is so intrinsic a property of metabolic processes that greatly reducing that production would entail fundamental redesign of those processes. Similarly, intervention in pathology is a "losing battle" if the damage that drives it is accumulating unabated. By contrast, intervention to remove the accumulating damage would sever the link between metabolism and pathology, and so has the potential to postpone aging indefinitely. We survey the major categories of such damage and the ways in which, with current or foreseeable biotechnology, they could be reversed. Such ways exist in all cases, implying that indefinite postponement of aging--which we term "engineered negligible senescence"--may be within sight. Given the major demographic consequences if it came about, this possibility merits urgent debate.

Entities:  

Mesh:

Year:  2002        PMID: 11976218     DOI: 10.1111/j.1749-6632.2002.tb02115.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  21 in total

1.  Life extension technologies: economic, psychological, and social considerations.

Authors:  Leigh Turner
Journal:  HEC Forum       Date:  2003-09

2.  Who wants to live forever?

Authors:  Jayne C Lucke; Wayne Hall
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

3.  Life extension research: health, illness, and death.

Authors:  Leigh Turner
Journal:  Health Care Anal       Date:  2004-06

Review 4.  Normal brain ageing: models and mechanisms.

Authors:  Emil C Toescu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

5.  Resistance to debate on how to postpone ageing is delaying progress and costing lives. Open discussions in the biogerontology community would attract public interest and influence funding policy.

Authors:  Aubrey D N J de Grey
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

6.  Medicine, ageing and human longevity. The economics and ethics of anti-ageing interventions.

Authors:  Charles McConnel; Leigh Turner
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

7.  A model of aging as accumulated damage matches observed mortality patterns and predicts the life-extending effects of prospective interventions.

Authors:  Chris Phoenix; Aubrey D N J de Grey
Journal:  Age (Dordr)       Date:  2007-09-18

Review 8.  Living longer: age retardation and autonomy.

Authors:  Elisabeth Hildt
Journal:  Med Health Care Philos       Date:  2008-07-31

9.  Toward priorities for aging research.

Authors:  Scott L Needham
Journal:  Rejuvenation Res       Date:  2014-04-08       Impact factor: 4.663

Review 10.  Healthy aging diets other than the Mediterranean: a focus on the Okinawan diet.

Authors:  Donald Craig Willcox; Giovanni Scapagnini; Bradley J Willcox
Journal:  Mech Ageing Dev       Date:  2014-01-21       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.